Mark K. Bennett

A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion

Thomas Söllner, Mark K. Bennett, Sidney W. Whiteheart et al. · Cell · 1993 · 1.9K citations

Life Sciences, Molecular Biology, Neuroscience +15

Syntaxin: A Synaptic Protein Implicated in Docking of Synaptic Vesicles at Presynaptic Active Zones

Mark K. Bennett, Nicole Calakos, Richard H. Scheller · Science · 1992 · 1.3K citations

Life Sciences, Molecular Biology, Neuroscience +17

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Matt I. Gross, Susan D. Demo, Jennifer B. Dennison et al. · Molecular Cancer Therapeutics · 2014 · 1.1K citations

Medicine, Oncology, Pharmacology +16

The natural history of nonalcoholic fatty liver: A follow-up study

Mohd R. Teli, Oliver James, Alastair D. Burt et al. · Hepatology · 1995 · 915 citations

Medicine, Pathology, Autopsy Pathology +11

Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma

Deborah J. Kuhn, Qing Chen, Peter M. Voorhees et al. · Blood · 2007 · 768 citations · Full text

Medicine, Oncology, Pharmacology +13